• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活细胞中的交联定位了恶唑烷酮类抗生素的作用位点。

Cross-linking in the living cell locates the site of action of oxazolidinone antibiotics.

作者信息

Colca Jerry R, McDonald William G, Waldon Daniel J, Thomasco Lisa M, Gadwood Robert C, Lund Eric T, Cavey Gregory S, Mathews W Rodney, Adams Lonnie D, Cecil Eric T, Pearson James D, Bock Jeffrey H, Mott John E, Shinabarger Dean L, Xiong Liqun, Mankin Alexander S

机构信息

Pharmacia Corporation, 301 Henrietta Street, Kalamazoo, MI 49001, USA.

出版信息

J Biol Chem. 2003 Jun 13;278(24):21972-9. doi: 10.1074/jbc.M302109200. Epub 2003 Apr 10.

DOI:10.1074/jbc.M302109200
PMID:12690106
Abstract

Oxazolidinone antibiotics, an important new class of synthetic antibacterials, inhibit protein synthesis by interfering with ribosomal function. The exact site and mechanism of oxazolidinone action has not been elucidated. Although genetic data pointed to the ribosomal peptidyltransferase as the primary site of drug action, some biochemical studies conducted in vitro suggested interaction with different regions of the ribosome. These inconsistent observations obtained in vivo and in vitro have complicated the understanding of oxazolidinone action. To localize the site of oxazolidinone action in the living cell, we have cross-linked a photoactive drug analog to its target in intact, actively growing Staphylococcus aureus. The oxazolidinone cross-linked specifically to 23 S rRNA, tRNA, and two polypeptides. The site of cross-linking to 23 S rRNA was mapped to the universally conserved A-2602. Polypeptides cross-linked were the ribosomal protein L27, whose N terminus may reach the peptidyltransferase center, and LepA, a protein homologous to translation factors. Only ribosome-associated LepA, but not free protein, was cross-linked, indicating that LepA was cross-linked by the ribosome-bound antibiotic. The evidence suggests that a specific oxazolidinone binding site is formed in the translating ribosome in the immediate vicinity of the peptidyltransferase center.

摘要

恶唑烷酮类抗生素是一类重要的新型合成抗菌药物,通过干扰核糖体功能来抑制蛋白质合成。恶唑烷酮作用的确切位点和机制尚未阐明。尽管遗传学数据表明核糖体肽基转移酶是药物作用的主要位点,但一些体外生化研究表明其与核糖体的不同区域相互作用。这些体内和体外获得的不一致观察结果使得对恶唑烷酮作用的理解变得复杂。为了在活细胞中定位恶唑烷酮的作用位点,我们将一种光活性药物类似物与完整的、活跃生长的金黄色葡萄球菌中的靶点进行了交联。恶唑烷酮特异性地交联到23S rRNA、tRNA和两种多肽上。与23S rRNA的交联位点被定位到普遍保守的A-2602。交联的多肽是核糖体蛋白L27,其N端可能到达肽基转移酶中心,以及LepA,一种与翻译因子同源的蛋白质。只有与核糖体相关的LepA,而不是游离蛋白,被交联,这表明LepA是被与核糖体结合的抗生素交联的。证据表明,在肽基转移酶中心紧邻区域的正在翻译的核糖体中形成了一个特定的恶唑烷酮结合位点。

相似文献

1
Cross-linking in the living cell locates the site of action of oxazolidinone antibiotics.活细胞中的交联定位了恶唑烷酮类抗生素的作用位点。
J Biol Chem. 2003 Jun 13;278(24):21972-9. doi: 10.1074/jbc.M302109200. Epub 2003 Apr 10.
2
The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria.恶唑烷酮类抗生素在活细菌和人体线粒体中的作用位点。
Mol Cell. 2007 May 11;26(3):393-402. doi: 10.1016/j.molcel.2007.04.005.
3
The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning.恶唑烷酮类抗生素会干扰核糖体肽基转移酶中心并影响tRNA定位。
Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13339-44. doi: 10.1073/pnas.0804276105. Epub 2008 Aug 29.
4
Oxazolidinone resistance mutations in 23S rRNA of Escherichia coli reveal the central region of domain V as the primary site of drug action.大肠杆菌23S rRNA中的恶唑烷酮抗性突变揭示了结构域V的中心区域是药物作用的主要位点。
J Bacteriol. 2000 Oct;182(19):5325-31. doi: 10.1128/JB.182.19.5325-5331.2000.
5
Protected nucleotide G2608 in 23S rRNA confers resistance to oxazolidinones in E. coli.23S核糖体RNA中受保护的核苷酸G2608赋予大肠杆菌对恶唑烷酮类药物的抗性。
Biochem Biophys Res Commun. 2005 Mar 11;328(2):471-6. doi: 10.1016/j.bbrc.2004.12.189.
6
Peptidyl transferase antibiotics perturb the relative positioning of the 3'-terminal adenosine of P/P'-site-bound tRNA and 23S rRNA in the ribosome.肽基转移酶抗生素会干扰核糖体中P/P'位点结合的tRNA的3'末端腺苷与23S rRNA的相对位置。
RNA. 1999 Aug;5(8):1003-13. doi: 10.1017/s1355838299990568.
7
Ribosomal RNA is the target for oxazolidinones, a novel class of translational inhibitors.核糖体RNA是恶唑烷酮类药物的作用靶点,恶唑烷酮类是一类新型的翻译抑制剂。
RNA. 1999 Jul;5(7):939-46. doi: 10.1017/s1355838299990210.
8
Catalytic properties of mutant 23 S ribosomes resistant to oxazolidinones.对恶唑烷酮耐药的突变型23 S核糖体的催化特性
J Biol Chem. 2003 Mar 14;278(11):9802-7. doi: 10.1074/jbc.m209249200.
9
Resistance mutations in 23 S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center.23 S rRNA中的耐药突变确定了蛋白质合成抑制剂利奈唑胺在核糖体肽基转移酶中心的作用位点。
J Mol Biol. 1999 Nov 19;294(1):93-101. doi: 10.1006/jmbi.1999.3247.
10
Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid.获得一个天然抗性基因使耐甲氧西林金黄色葡萄球菌的临床菌株对合成抗生素利奈唑胺产生抗性。
Mol Microbiol. 2007 Jun;64(6):1506-14. doi: 10.1111/j.1365-2958.2007.05744.x.

引用本文的文献

1
Recent Biochemical Advances in Antitubercular Drugs: Challenges and Future.近期抗结核药物的生物化学进展:挑战与未来。
Curr Top Med Chem. 2024;24(21):1829-1855. doi: 10.2174/0115680266286294240610102911.
2
Exploring antibiotic resistance with chemical tools.利用化学工具探索抗生素耐药性。
Chem Commun (Camb). 2023 May 18;59(41):6148-6158. doi: 10.1039/d3cc00759f.
3
How to build a protoribosome: structural insights from the first protoribosome constructs that have proven to be catalytically active.如何构建原核核糖体:来自首个已被证明具有催化活性的原核核糖体构建体的结构见解。
RNA. 2023 Mar;29(3):263-272. doi: 10.1261/rna.079417.122. Epub 2023 Jan 5.
4
Phage-Related Ribosomal Proteases (Prps): Discovery, Bioinformatics, and Structural Analysis.噬菌体相关核糖体蛋白酶(Prps):发现、生物信息学与结构分析
Antibiotics (Basel). 2022 Aug 16;11(8):1109. doi: 10.3390/antibiotics11081109.
5
Molecular Mechanisms of Drug Resistance in .肿瘤多药耐药相关基因的分子机制研究进展
Int J Mol Sci. 2022 Jul 22;23(15):8088. doi: 10.3390/ijms23158088.
6
Successful treatment of linezolid-induced severe lactic acidosis with continuous venovenous hemodiafiltration: A case report.连续性静脉-静脉血液透析滤过成功治疗利奈唑胺所致严重乳酸酸中毒:一例报告
Saudi Pharm J. 2022 Feb;30(2):108-111. doi: 10.1016/j.jsps.2021.12.021. Epub 2021 Dec 31.
7
Structural basis for context-specific inhibition of translation by oxazolidinone antibiotics.结构基础:恶唑烷酮类抗生素对翻译的特定语境抑制。
Nat Struct Mol Biol. 2022 Feb;29(2):162-171. doi: 10.1038/s41594-022-00723-9. Epub 2022 Feb 14.
8
The risk factors of linezolid-induced lactic acidosis: A case report and review.利奈唑胺引起乳酸酸中毒的危险因素:一例病例报告及文献复习
Medicine (Baltimore). 2018 Sep;97(36):e12114. doi: 10.1097/MD.0000000000012114.
9
Antibacterial Activity and Mechanism of Action of Aspidinol Against Multi-Drug-Resistant Methicillin-Resistant .阿斯皮多醇对多重耐药耐甲氧西林菌的抗菌活性及作用机制
Front Pharmacol. 2018 Jun 13;9:619. doi: 10.3389/fphar.2018.00619. eCollection 2018.
10
Intramolecular ring-opening from a CO-derived nucleophile as the origin of selectivity for 5-substituted oxazolidinone from the (salen)Cr-catalyzed [aziridine + CO] coupling.由源自一氧化碳的亲核试剂引发的分子内环开环反应,是(salen)Cr催化的[氮丙啶 + 一氧化碳]偶联反应中5-取代恶唑烷酮选择性的起源。
Chem Sci. 2015 Feb 1;6(2):1293-1300. doi: 10.1039/c4sc02785j. Epub 2014 Nov 21.